Stability of the HSV-2 <i>US-6</i> Gene in the del II, del III, <i>CP77</i>, and <i>I8R</i>-<i>G1L</i> Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells
The modified vaccinia virus Ankara (MVA), a severely attenuated strain of vaccinia virus, is a promising vector platform for viral-vectored vaccine development because of its attributes of efficient transgene expression and safety profile, among others. Thus, transgene stability in MVA is important...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/1/137 |
id |
doaj-71376b817f6c4709834edbbf9cfca30d |
---|---|
record_format |
Article |
spelling |
doaj-71376b817f6c4709834edbbf9cfca30d2020-11-25T02:38:13ZengMDPI AGVaccines2076-393X2020-03-018113710.3390/vaccines8010137vaccines8010137Stability of the HSV-2 <i>US-6</i> Gene in the del II, del III, <i>CP77</i>, and <i>I8R</i>-<i>G1L</i> Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in CellsVajini N. Atukorale0Jerry P. Weir1Clement A. Meseda2Division of Viral Products, Center for Biologics Evaluation and Research, U S Food & Drug Administration, Silver Spring, MD 20993, USADivision of Viral Products, Center for Biologics Evaluation and Research, U S Food & Drug Administration, Silver Spring, MD 20993, USADivision of Viral Products, Center for Biologics Evaluation and Research, U S Food & Drug Administration, Silver Spring, MD 20993, USAThe modified vaccinia virus Ankara (MVA), a severely attenuated strain of vaccinia virus, is a promising vector platform for viral-vectored vaccine development because of its attributes of efficient transgene expression and safety profile, among others. Thus, transgene stability in MVA is important to assure immunogenicity and efficacy. The global GC content of the MVA genome is 33%, and GC-rich sequences containing runs of C or G nucleotides have been reported to be less stable with passage of MVA vectors in cells. The production of recombinant MVA vaccines requires a number of expansion steps in cell culture, depending on production scale. We assessed the effect of extensive passage of four recombinant MVA vectors on the stability of the GC-rich herpes simplex type 2 (HSV-2) <i>US6</i> gene encoding viral glycoprotein D (gD2) inserted at four different genomic sites, including the deletion (del) II and del III sites, the <i>CP77</i> gene locus (<i>MVA_009−MVA_013</i>) and the <i>I8R</i>-<i>G1L</i> intergenic region. Our data indicate that after 35 passages, there was a reduction in gD2 expression from del II, del III and <i>CP77</i> sites. Sequencing analysis implicated <i>US6</i> deletion and mutational events as responsible for the loss of gD2 expression. By contrast, 85.9% of recombinant plaques expressed gD2 from the <i>I8R</i>-<i>G1L</i> site, suggesting better accommodation of transgenes in this intergenic region. Thus, the <i>I8R</i>-<i>G1L</i> intergenic region may be more useful for transgene insertion for enhanced stability.https://www.mdpi.com/2076-393X/8/1/137modified vaccinia virus ankaravaccine stabilitytransgenehsv-2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vajini N. Atukorale Jerry P. Weir Clement A. Meseda |
spellingShingle |
Vajini N. Atukorale Jerry P. Weir Clement A. Meseda Stability of the HSV-2 <i>US-6</i> Gene in the del II, del III, <i>CP77</i>, and <i>I8R</i>-<i>G1L</i> Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells Vaccines modified vaccinia virus ankara vaccine stability transgene hsv-2 |
author_facet |
Vajini N. Atukorale Jerry P. Weir Clement A. Meseda |
author_sort |
Vajini N. Atukorale |
title |
Stability of the HSV-2 <i>US-6</i> Gene in the del II, del III, <i>CP77</i>, and <i>I8R</i>-<i>G1L</i> Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells |
title_short |
Stability of the HSV-2 <i>US-6</i> Gene in the del II, del III, <i>CP77</i>, and <i>I8R</i>-<i>G1L</i> Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells |
title_full |
Stability of the HSV-2 <i>US-6</i> Gene in the del II, del III, <i>CP77</i>, and <i>I8R</i>-<i>G1L</i> Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells |
title_fullStr |
Stability of the HSV-2 <i>US-6</i> Gene in the del II, del III, <i>CP77</i>, and <i>I8R</i>-<i>G1L</i> Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells |
title_full_unstemmed |
Stability of the HSV-2 <i>US-6</i> Gene in the del II, del III, <i>CP77</i>, and <i>I8R</i>-<i>G1L</i> Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells |
title_sort |
stability of the hsv-2 <i>us-6</i> gene in the del ii, del iii, <i>cp77</i>, and <i>i8r</i>-<i>g1l</i> sites in modified vaccinia virus ankara after serial passage of recombinant vectors in cells |
publisher |
MDPI AG |
series |
Vaccines |
issn |
2076-393X |
publishDate |
2020-03-01 |
description |
The modified vaccinia virus Ankara (MVA), a severely attenuated strain of vaccinia virus, is a promising vector platform for viral-vectored vaccine development because of its attributes of efficient transgene expression and safety profile, among others. Thus, transgene stability in MVA is important to assure immunogenicity and efficacy. The global GC content of the MVA genome is 33%, and GC-rich sequences containing runs of C or G nucleotides have been reported to be less stable with passage of MVA vectors in cells. The production of recombinant MVA vaccines requires a number of expansion steps in cell culture, depending on production scale. We assessed the effect of extensive passage of four recombinant MVA vectors on the stability of the GC-rich herpes simplex type 2 (HSV-2) <i>US6</i> gene encoding viral glycoprotein D (gD2) inserted at four different genomic sites, including the deletion (del) II and del III sites, the <i>CP77</i> gene locus (<i>MVA_009−MVA_013</i>) and the <i>I8R</i>-<i>G1L</i> intergenic region. Our data indicate that after 35 passages, there was a reduction in gD2 expression from del II, del III and <i>CP77</i> sites. Sequencing analysis implicated <i>US6</i> deletion and mutational events as responsible for the loss of gD2 expression. By contrast, 85.9% of recombinant plaques expressed gD2 from the <i>I8R</i>-<i>G1L</i> site, suggesting better accommodation of transgenes in this intergenic region. Thus, the <i>I8R</i>-<i>G1L</i> intergenic region may be more useful for transgene insertion for enhanced stability. |
topic |
modified vaccinia virus ankara vaccine stability transgene hsv-2 |
url |
https://www.mdpi.com/2076-393X/8/1/137 |
work_keys_str_mv |
AT vajininatukorale stabilityofthehsv2ius6igeneinthedeliideliiiicp77iandii8riig1lisitesinmodifiedvacciniavirusankaraafterserialpassageofrecombinantvectorsincells AT jerrypweir stabilityofthehsv2ius6igeneinthedeliideliiiicp77iandii8riig1lisitesinmodifiedvacciniavirusankaraafterserialpassageofrecombinantvectorsincells AT clementameseda stabilityofthehsv2ius6igeneinthedeliideliiiicp77iandii8riig1lisitesinmodifiedvacciniavirusankaraafterserialpassageofrecombinantvectorsincells |
_version_ |
1724792137145384960 |